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The ¢rst part of Dr. Forloni’s comment is a review of
previous work on PrP106^126 and does not need further ex-
position beyond that given in our earlier reply to the comment
of Dr. Brown [1] concerning the report ‘Neurotoxicity of
prion peptide 106^126 not con¢rmed’.
In the criticism of our work, Dr. Forloni reproaches us for
not having identi¢ed the putative contaminant(s) of our
PrP106^126 preparation responsible for its neurotoxicity.
This notion is hard to understand as we had not detected
any toxicity in our batches of the peptide. Thus, there was
no toxic contaminant to be chased. Di⁄cult to understand is
also the view that neurotoxicity should depend on where and
when the peptide was synthesized. Di¡erent batches of the
same peptide with a de¢ned structure may safely be assumed
to behave in identical fashion under identical conditions, i.e.
to assume the same conformation and to have the same ag-
gregation properties. We can but repeat what we wrote in our
reply to Dr. David Brown’s comment [1]. We are not con-
vinced by the comments our report has elicited that we have
missed an important experimental variable in attempting to
observe the reported toxicity of PrP106^126.
Dr. Forloni concludes his comment with the advice that we
should test several commercially available batches of PrP106^
126. When we found the peptide to be non-toxic in our hands,
we indeed contacted Dr. Forloni and asked for a sample that
had proven neurotoxic in his laboratory. Unfortunately in
vain. We still would welcome the opportunity to exchange
peptide material between the two laboratories.
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